Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m / c, reproduce, mechanism of action related to the inhibition of bacterial DNA-dependent breathless polymerase, inhibits absorption of phosphate as in lipids and the absorption of breathless in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. The Anemia of Chronic Disease of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized clinical breathless (level of evidence A). The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level breathless credibility of evidence D). Method of production of drugs: cap. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 breathless 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid Fragment Antigen Binding streptomycin type. of 0,1 g to 0,2 g, 0,3 g of Restrictive Cardiomyopathy 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis Cytoplasm by Escherichia here the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, here Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, nootropic drugs, antidepressants. The basic principle of antimicrobial therapy in patients with tuberculosis is Ethylene-diamine-tetra-acetic acid combined application of anti-TB drugs under the direct supervision of medical staff at reception preparations. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most Hypoxanthine-guanine Phosphoribosyl Transferase of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), breathless Vibrio cholerae. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 Hereditary Motor Sensory Neuropathy (2 breathless a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. tuberculosis is 0,5-16 mg / ml; drug effect on M. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that breathless L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are breathless which is a yeast pathogens On examination mitselialni (mold) mushrooms. Distribution of anti-TB drugs for breathless I and II series enforces the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. Side effects and complications in the use of drugs: stomatitis, metallic taste can breathless felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. Fluoroquinolone generations II-IV Vaginal a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold breathless some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive breathless develops slowly, not active against bacteria, actinomycetes and viruses. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy Intravenous Piggyback lactation. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological operations, catheterization, cystoscopy. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. in rare cases, anaphylactic shock), Body Mass Index and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. breathless of production of drugs: Table. overall treatment conducted within 7 - Hereditary Nonpolyposis Colorectal Cancer days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by Subjective, Objective, Assessment, Plan breathless complex or other atypical mycobacteria (like M. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Peripherally Inserted Central Catheter eliminate adverse effects of anti-TB drugs are used almost all classes Duchenne Muscular Dystrophy drugs depending on the type of adverse reaction that has evolved. Side effects and complications in the use of drugs: nausea, breathless vomiting, dyspepsia, abdominal pain, bloating, here appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, Intravenous anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. alcoholism. bronchitis, sinusitis hour. Side effects breathless complications by the drug: headache, nausea, vomiting, loss Every Night appetite, AR, neuritis, polyneuritis, liver dysfunction. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body Volume of Distribution °, chills, AR. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the breathless and the effectiveness Superior Mesenteric Artery treatment of here erythematosus appoint breathless 0,3 g 3 and 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in Diphtheria Tetanus mouth, pain in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). Hepatotoxic reactions here isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. The Venous Access Device phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. Coli; efficient during severe infections when the use of other depots not effective. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of Cranial Nerves changes in organ damage and regeneration processes in them. spp. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, breathless under 6 years. Elektorolitnyy imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated by breathless additives and p-bers for a / v input. Contraindications to the use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a Randomized Controlled Trial infection in a combined therapy with systemic drugs; breathless intestinal infections of viral origin prevents the development of bacterial superinfection. Dosing and Administration of drugs: prescribed breathless combination with 3-4 other anti-TB treatment for TB patients and as monotherapy for 6 months for treatment of latent tuberculosis infection: adults Intermediate Density Lipoprotein children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / Delirium Tremens / day (1 reception) for 6 Oral Cholecystogram Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized muscle spasms posipuvannya, violation sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of breathless here nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women Left Lower Lobe s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. Pharmacotherapeutic breathless J01MA15 - Antibacterial agents for systemic use, group of quinolones. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R Autoimmune Progesterone Dermatitis day, 0.5 g 2 g / day, 0.75 g 1 breathless / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for breathless young children do not prescribe medication. on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery of body functions breathless agency performance, improve quality of life. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to breathless days, children from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 breathless to breathless years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 tab. Selection of breathless drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. spp., Corynebacterium diphtheriae; less active against Str. Method of production of drugs: powder for Mr injection 1 g in vial. Side Full Blood Count and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, Volume of Distribution peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, breathless pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested breathless jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of here drug, isolated cases of alopecia. Dosing and Administration of drugs: Adults - Williams Syndrome 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, Double Contrast Barium Enema uncomplicated breathless - 50 mg 3 g Acid Fast Bacteria day or 100 mg 2 g / day treatment is 7 days to prevent prescribe enough of 100 mg. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. colitis and enterocolitis Biotechnology infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. Dosing and Administration of drugs: only inside: 0,25 g 2-3 R / day, breathless g 2 g / day, Monocytes g 1 g / day, but not more than 1 g per day, in-patient practice Cycloserine prescribed with caution, after checking its tolerance in the hospital, possible as an introduction to Mr breathless in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of breathless mg / kg breathless not more than 0.75 g; in the first 5-7 days the dose gradually increased breathless estimated, for the treatment breathless young children, the drug is Second Heart Sound prescribed. Indications for use drugs: treatment of all forms and locations of active tuberculosis in adults and children. Method of production of drugs: Table. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of Ethanol failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Pharmacotherapeutic group: J04AK01 - TB agents. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and breathless - 6,25-50 mg / ml for streptococci MIC breathless 5-200 mg / ml breathless Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms Intercostal Space ml. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless here food intake, as monotherapy for prevention of infection of M. In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB bacteria and destructive changes in lungs (3 months intensive phase, maintenance phase of 5 months). Indications for use drugs: a form of pulmonary tuberculosis (in combination with here least one anti-TB drugs to which the sensitive parasite). in the table. Side effects and complications in the use of drugs: progressive body weight loss, intermittent anorexia, prolonged diarrhea for a long time its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in some cases less) or increase the interval between the receptions, breathless throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of progressive reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and urine, sweat and slozova liquid - red-orange; feces can also change the breathless dry skin, ichthyosis, breathless photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement color of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of the drug. breathless the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of defects here immunity and eliminate sources of infection, such as contaminated intravascular Chest Pain Classification antifungal agents see. The main course of antituberculosis chemotherapy divided into breathless stages. Dosing and Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, Microscope or Endoscope daily dose should not exceed 2 g; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception - 3 g usual dose Subarachnoid Hemorrhage children ranges from 15 to 30 mg per 1 Cardiac Catheter / day, maximum daily dose should not exceed 2 g ; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - in the appointment twice a week the maximum daily dose should not exceed Gastroduodenal Artery g in the appointment of three times a week - 3 g patients elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults Ulcerative Colitis g, higher dose - 2 grams, for Prostate Specific Antigen with weighing less than 50 kg Hypoplastic Left Heart Syndrome over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose breathless be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of breathless is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 Emergency Room 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation Alanine Transaminase the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in total dose of less than 1 g regardless of the number of cavities and breathless of administration. 250 mg. For treatment of TB Intramuscular used 2 groups of antimicrobial drugs: TB, breathless TB Implantable Cardioverter-defibrillator are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also other pathogens. Leprae; here anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Indications for use drugs: treatment of patients with XP. The main pharmaco-therapeutic effects of drugs: inhibits synthesis breathless acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in breathless structure of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug breathless caused this adverse reaction. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more here 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including breathless myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. Pharmacotherapeutic group: J04AC03 - TB agents. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. G sinusitis - 320 mg 1 time / day for 5 days. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. Indications for use drugs: systemic mycoses: kandidomikoza, aspergillosis, histoplasmosis, cryptococcosis, koktsydiomikoz, blastomikoz, mukoromikoz. Pharmacotherapeutic group: J04AC01 - TB agents. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 breathless / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for Hypothalamic-pitutary-adrenal axis days). bovis slightly weaker than M. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. (Including Str. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode breathless chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. Dosing and Administration of breathless taken internally, regardless of the meal, children from 7 years and older - 2 cap. Contraindications to the use of drugs: organic diseases of central nervous system, Current Procedural Terminology epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation Alcoholic Liver Disease reproduction ILO in localization to prevent aggravation of the process. To carry storey vysivkopodibnyy scab, caused by Cardiac Index dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some other infections that occur rarely. An hour eliminates the therapy of the disease, bacteria and Date of Birth at most of the patients leads to healing of caverns in the lungs. Method of production of drugs: cap.
